Reuters logo
BRIEF-Ocera Therapeutics Q4 loss per share $0.22
March 10, 2017 / 11:13 AM / 6 months ago

BRIEF-Ocera Therapeutics Q4 loss per share $0.22

March 10 (Reuters) - Ocera Therapeutics Inc

* Ocera Therapeutics reports fourth quarter and full year 2016 financial results and provides corporate update

* Q4 loss per share $0.22

* Q4 earnings per share view $-0.34 -- Thomson Reuters I/B/E/S

* Q4 revenue $512,000

* Q4 revenue view $16,000 -- Thomson Reuters I/B/E/S

* Ocera Therapeutics says anticipates it will have sufficient cash to fund operations into Q2 of 2018 based on its current operating plan and other things Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below